Professor of Medicine
University of Pennsylvania School of Medicine
Director, Center for Inflammatory Bowel Disease
Department of Medicine
Division of Gastroenterology

Dr. Lichtenstein is director of the Inflammatory Bowel Disease Center and an associate professor of medicine in the Gastrointestinal Division at the Hospital of the University of Pennsylvania and the University of Pennsylvania School of Medicine. He earned his medical degree from the Mount Sinai School of Medicine in New York. He completed his internship and residency in internal medicine at Duke University Medical Center, Durham, North Carolina, followed by a fellowship in gastroenterology at the University of Pennsylvania School of Medicine. His current research interests encompass therapies for the treatment of ulcerative colitis and Crohn's disease. Dr. Lichtenstein serves on numerous editorial boards, including Inflammatory Bowel Diseases and Digestive Diseases and Sciences. He has also recently served as medical secretary for the American Board of Internal Medicine. Dr. Lichtenstein reports he has received funding from Abbott Corporation, AstraZeneca, Axcan Pharma, Berlex, Celgene, Celltech, Centocor, Elan, Falk Pharma, Faro Pharmaceuticals, Genetics Institute, Human Genome Sciences, InKine Inc., Intesco, ISIS Corporation, Millennium Pharmaceuticals, Otsuka, Procter & Gamble, Prometheus Laboratories, Protein Design Labs, Protomed Scientific, Salix Pharmaceuticals, Schering-Plough, Serono, Shire Pharmaceuticals, SmithKline Beecham, Solvay Pharmaceuticals, Synta Pharmaceuticals, UCB and Wyeth.

The nationally renowned Gastroenterology Division of the University of Pennsylvania provides comprehensive resources for the diagnosis and therapy of diseases of the digestive tract (esophagus, stomach, small intestine and colon), pancreas and liver. Our focus is to facilitate the development of patient care, education, and research programs in digestive liver and pancreatic diseases.

Clinical programs benefit from the largest group of specialists in digestive and liver disease in the greater Philadelphia region, bringing a breadth of expertise that ensures comprehensive care. Discoveries into the pathogenesis and therapy of digestive liver and pancreatic diseases are facilitated by a large research base at the University and NIH Digestive Disease Research Center, funded through the National Institutes of Health.

The Raymond and Ruth Perelman Center for Advanced Medicine (below), opened in 2008, is a state-of-the-art, 360,000+ square foot outpatient facility adjacent to the Hospital of the University of Pennsylvania. It is the home of the HUP Gastroenterology outpatient clinics and endoscopy unit.